Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer
Rachel Howard, Peter A. Kanetsky, Kathleen M. Egan
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 240

Showing 1-25 of 240 citing articles:

Systemic immunity in cancer
Kamir J. Hiam-Galvez, Breanna M. Allen, Matthew H. Spitzer
Nature reviews. Cancer (2021) Vol. 21, Iss. 6, pp. 345-359
Open Access | Times Cited: 972
Neutrophil-to-lymphocyte ratio, past, present and future perspectives
Roman Záhorec
Bratislavské lekárske listy/Bratislava medical journal (2021) Vol. 122, Iss. 07, pp. 474-488
Open Access | Times Cited: 551
Targeting the gut and tumor microbiota in cancer
Elizabeth M. Park, Manoj Chelvanambi, Neal Bhutiani, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 690-703
Closed Access | Times Cited: 320
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress
Elisa Montaldo, Eleonora Lusito, Valentina Bianchessi, et al.
Nature Immunology (2022) Vol. 23, Iss. 10, pp. 1470-1483
Open Access | Times Cited: 118
Periodontitis pathogen Porphyromonas gingivalis promotes pancreatic tumorigenesis via neutrophil elastase from tumor-associated neutrophils
Qin Tan, Xiao Ma, Bing Yang, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 79
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance
Christina Guo, Adam Sharp, Bora Gürel, et al.
Nature (2023) Vol. 623, Iss. 7989, pp. 1053-1061
Open Access | Times Cited: 53
CellCharter reveals spatial cell niches associated with tissue remodeling and cell plasticity
Marco Varrone, Daniele Tavernari, Albert Santamaria‐Martínez, et al.
Nature Genetics (2023) Vol. 56, Iss. 1, pp. 74-84
Open Access | Times Cited: 47
Neutrophil-to-lymphocyte ratio an inflammatory biomarker, and prognostic marker in heart failure, cardiovascular disease and chronic inflammatory diseases: New insights for a potential predictor of anti-cytokine therapy responsiveness
Artemio García‐Escobar, Silvio Vera‐Vera, Daniel Tébar Márquez, et al.
Microvascular Research (2023) Vol. 150, pp. 104598-104598
Closed Access | Times Cited: 45
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
Jaroslav Žák, Isaraphorn Pratumchai, Brett S. Marro, et al.
Science (2024) Vol. 384, Iss. 6702
Closed Access | Times Cited: 43
Unraveling the clinical significance and prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammation response index, and delta neutrophil index: An extensive literature review
Mehmet Muzaffer Islam, Merve OSOYDAN SATICI, Serkan Emre Eroglu
Turkish Journal of Emergency Medicine (2024) Vol. 24, Iss. 1, pp. 8-19
Open Access | Times Cited: 35
Inflammatory markers predict efficacy of immunotherapy in advanced non-small cell lung cancer: a preliminary exploratory study
Yingqing Zhang, Na Yan, Yan Feng, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti–PD‐1 therapy
Sirish Dharmapuri, Umut Özbek, Jung‐Yi Lin, et al.
Cancer Medicine (2020) Vol. 9, Iss. 14, pp. 4962-4970
Open Access | Times Cited: 107
Transferring clinically established immune inflammation markers into exercise physiology: focus on neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index
David Walzik, Niklas Joisten, Jonas Zacher, et al.
European Journal of Applied Physiology (2021) Vol. 121, Iss. 7, pp. 1803-1814
Open Access | Times Cited: 90
The Neutrophil-to-Monocyte Ratio and Lymphocyte-to-Neutrophil Ratio at Admission Predict In-Hospital Mortality in Mexican Patients with Severe SARS-CoV-2 Infection (Covid-19)
Salma A. Rizo-Téllez, Lucia A. Méndez‐García, Cruz Flores-Rebollo, et al.
Microorganisms (2020) Vol. 8, Iss. 10, pp. 1560-1560
Open Access | Times Cited: 86
The Pan-Immune-Inflammation-Value Predicts the Survival of Patients with Human Epidermal Growth Factor Receptor 2 (HER2)—Positive Advanced Breast Cancer Treated with First-Line Taxane-Trastuzumab-Pertuzumab
Francesca Ligorio, Giovanni Fucá, Emma Zattarin, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1964-1964
Open Access | Times Cited: 82
Low peripheral blood derived neutrophil-to-lymphocyte ratio (dNLR) is associated with increased tumor T-cell infiltration and favorable outcomes to first-line pembrolizumab in non-small cell lung cancer
Joao V. Alessi, Biagio Ricciuti, Stephanie Alden, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 11, pp. e003536-e003536
Open Access | Times Cited: 77
Efficacy and safety of atezolizumab plus bevacizumab in Korean patients with advanced hepatocellular carcinoma
Jaekyung Cheon, Changhoon Yoo, Jung Yong Hong, et al.
Liver International (2021) Vol. 42, Iss. 3, pp. 674-681
Closed Access | Times Cited: 56
Evaluation of Optimal Threshold of Neutrophil-Lymphocyte Ratio and Its Association With Survival Outcomes Among Patients With Head and Neck Cancer
Sung Jun, Han Yu, Michael Khan, et al.
JAMA Network Open (2022) Vol. 5, Iss. 4, pp. e227567-e227567
Open Access | Times Cited: 38
A first-in-human study of the fibroblast activation protein–targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors
Ignacio Melero, Tamara Tanos, Mariana Bustamante, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 695
Closed Access | Times Cited: 36
Malnutrition in cancer patients: Causes, consequences and treatment options
Jann Arends
European Journal of Surgical Oncology (2023) Vol. 50, Iss. 5, pp. 107074-107074
Open Access | Times Cited: 35
Baseline and early changes in the neutrophil–lymphocyte ratio (NLR) predict survival outcomes in advanced colorectal cancer patients treated with immunotherapy
Hui Ouyang, Bijing Xiao, Yan Huang, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110703-110703
Open Access | Times Cited: 34
Microbes translocation from oral cavity to nasopharyngeal carcinoma in patients
Ying Liao, Yanxia Wu, Minzhong Tang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Age‐ and sex‐specific pediatric reference intervals for neutrophil‐to‐lymphocyte ratio, lymphocyte‐to‐monocyte ratio, and platelet‐to‐lymphocyte ratio
Julia Moosmann, Anja Krusemark, Sven Dittrich, et al.
International Journal of Laboratory Hematology (2021) Vol. 44, Iss. 2, pp. 296-301
Open Access | Times Cited: 54
Mechanisms of hyperprogressive disease after immune checkpoint inhibitor therapy: what we (don’t) know
Simone Camelliti, Valentino Le Noci, Francesca Bianchi, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 50
Association of severe lymphopenia and disease progression in unresectable locally advanced non-small cell lung cancer treated with definitive chemoradiation and immunotherapy
Cole Friedes, Turja Chakrabarti, Sarah Olson, et al.
Lung Cancer (2021) Vol. 154, pp. 36-43
Closed Access | Times Cited: 42
Page 1 - Next Page

Scroll to top